Our results indicate that targeting SPP1+ macrophages represents a promising radiosensitizing strategy in NSCLC by reducing macrophage-mediated immunosuppression and enhancing CD8+ T cell infiltration, thereby improving RT efficacy. Here, SPP1 is linked to non-small cell lung carcinoma.